arrow
返回
K

Kendra Sweet

Moffitt Cancer Center

35H指数
374论文数
5.6K被引数
收录论文 48
发表时间
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia去甲基化药物与Venetoclax联合方案是老年(≥70岁)新诊断低危急性髓系白血病患者接受强化化疗的安全有效替代方案。
err2025-08-07
err0
PREAI
errSomedeb Ball; Akriti G. Jain; Najla Al Ali; Luis E. Aguirre; Jan Philipp Bewersdorf; Andrew Kent; Ameera Rose; Alexander Hayden; Alexa Siddon; Jill Lykon; Ellen Madarang; David M. Swoboda; Eric Padron; Kendra Sweet; David A. Sallman; Jeffrey Lancet; Hetty E. Carraway; Justin Watts; Amer Zeidan; Daniel A. Pollyea; Rami S. Komrokji
err分享
err收藏
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease Progression惰性慢性髓单核细胞白血病表型的特征描述及疾病进展的动态特征
err2025-03-29
err0
PREAI
errLuis E. Aguirre; Somedeb Ball; Akriti Jain; Najla Al Ali; David A. Sallman; Andrew Kuykendall; Kendra Sweet; Jeffrey E. Lancet; Eric Padron; Rami S. Komrokji
err分享
err收藏
Phase 1/1b Dose Escalation and Expansion of CPX-351 in Combination with Gemtuzumab Ozogamicin in Newly Diagnosed Acute Myeloid LeukemiaI期/II期剂量递增和扩展研究:CPX-351联合Gemtuzumab Ozogamicin治疗新诊断急性髓性白血病
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errChan, Onyee; Sweet, Kendra L.; Talati, Chetasi; Zahra, Fatima Tuz; Nardelli, Lisa Ann; Lamba, Jatinder K.; Kim, Jongphil; Song, Jinming; Xie, Zhuoer; Yun, Seongseok; Kuykendall, Andrew T.; Padron, Eric; Walker, Alison R.; Komrokji, Rami S.; Lancet, Jeffrey E.; Sallman, David
err分享
err收藏
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia
err2024-09-07
err0
errOAAI
errJain, Akriti G.; Volpe, Virginia O.; Wang, Chen; Ball, Somedeb; Tobon, Katherine; Chan, Onyee; Padron, Eric; Kuykendall, Andrew; Lancet, Jeffrey E.; Komrokji, Rami; Sallman, David A.; Sweet, Kendra L.
err分享
err收藏
err分享
err收藏
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML慢性期CML患者达沙替尼胸腔积液的发生率以及将治疗转换为不同TKI的效果
err2024-04-18
err3
errOAAI
errJain, Akriti G.; Gesiotto, Quinto; Ball, Somedeb; Nodzon, Lisa; Rodriguez, Amanda; Chan, Onyee; Padron, Eric; Kuykendall, Andrew; Komrokji, Rami; Sallman, David A.; Lancet, Jeffrey E.; Pinilla-Ibarz, Javier; Sweet, Kendra
err分享
err收藏
Mutations highly speci fi c for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML
err2024-02-28
err5
errOAAI
errChan, Onyee; Al Ali, Najla; Tashkandi, Hammad; Ellis, Austin; Ball, Somedeb; Grenet, Justin; Hana, Caroline; Deutsch, Yehuda; Zhang, Ling; Hussaini, Mohammad; Song, Jinming; Yun, Seongseok; Talati, Chetasi; Kuykendall, Andrew; Padron, Eric; Walker, Alison; Roboz, Gail; Desai, Pinkal; Sallman, David; Sweet, Kendra; Komrokji, Rami; Lancet, Jeffrey
err分享
err收藏
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia低风险骨髓增生异常综合征进展的模式: 预测进展为高风险骨髓增生异常综合征和急性髓系白血病的因素
err2024-02-01
err3
errOAAI
errJain, Akriti G.; Ball, Somedeb; Aguirre, Luis; Al Ali, Najla; Kaldas, David; Tinsley-Vance, Sara; Kuykendall, Andrew; Chan, Onyee; Sweet, Kendra; Lancet, Jeffrey E.; Padron, Eric; Sallman, David A.; Komrokji, Rami
err分享
err收藏
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia
err2023-09-13
err0
errOAAI
errPatel, Parth C.; Ball, Somedeb; Jain, Akriti G.; Wang, Chen; Hussaini, Mohammad O.; Aguirre, Luis E.; Chan, Onyee; Yun, Seongseok; Kuykendall, Andrew; Padron, Eric; Sweet, Kendra; Lancet, Jeffrey E.; Komrokji, Rami S.; Sallman, David A.
err分享
err收藏
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
err2023-07-17
err5
errOAAI
errKomrokji, Rami S.; Aguirre, Luis E.; Al Ali, Najla H.; Chan, Onyee; Xie, Zhuoer; Kuykendall, Andrew; Sweet, Kendra; Lancet, Jeffrey E.; Padron, Eric; Sallman, David A.
err分享
err收藏
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes
errLEUKEMIA
IF13.4
err2023-05-05
err12
PREAI
errAguirre, Luis E. E.; Ali, Najla Al; Sallman, David A. A.; Ball, Somedeb; Jain, Akriti G. G.; Chan, Onyee; Tinsley-Vance, Sara M. M.; Kuykendall, Andrew; Sweet, Kendra; Lancet, Jeffrey E. E.; Padron, Eric; Komrokji, Rami S. S.
err分享
err收藏
Acute Myeloid Leukemia, Version 3.2023
err2023-05-01
err60
errOAAI
errPollyea, Daniel A.; Altman, Jessica K.; Assi, Rita; Bixby, Dale; Fathi, Amir T.; Foran, James M.; Gojo, Ivana; Hall, Aric C.; Jonas, Brian A.; Kishtagari, Ashwin; Lancet, Jeffrey; Maness, Lori; Mangan, James; Mannis, Gabriel; Marcucci, Guido; Mims, Alice; Moriarty, Kelsey; Ali, Moaath Mustafa; Neff, Jadee; Nejati, Reza; Olin, Rebecca; Percival, Mary -Elizabeth; Perl, Alexander; Przespolewski, Amanda; Rao, Dinesh; Ravandi, Farhad; Shallis, Rory; Shami, Paul J.; Stein, Eytan; Stone, Richard M.; Sweet, Kendra; Thota, Swapna; Uy, Geoffrey; Vachhani, Pankit; Cassara, Carly J.; Freedman-Cass, Deborah A.; Stehman, Katie
err分享
err收藏
A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced myeloid malignancies
err2023-04-14
err1
PREAI
errDiNardo, Courtney D.; Montesinos, Pau; Benajiba, Lina; Triguero, Ana; Recher, Christian; Schuh, Andre C.; Heiblig, Mael; Bajel, Ashish; Pigneux, Arnaud; Alonso-Domiguez, Juan M.; Fathi, Amir T.; Grove, Carolyn; Hou, Hsin-An; Heuser, Michael; Assouline, Sarit; Fleming, Shaun; Shin, Dong-Yeop; Sweet, Kendra; Odenike, Olatoyosi; Altman, Jessica; Ooi, Melissa Gaik Ming; Lao Zhentang; Vey, Nobert; Zeidner, Joshua; Salhotra, Amandeep; Wang, Eunice; Schiller, Gary; Porkka, Kimmo; Zuckerman, Tsila; Havelange, Violaine; Jonas, Brian A.; Narayanan, Sujaatha; Jang, Jun Ho; Lee, Je-Hwan; Szpurka, Anna M.; Heirich, Dana; Chen, Hsiao Rong; Hanft, Violet; Zhao, Junjie; Gueorguieva, Ivelina; Zhang, Yin; Stein, Eytan M.
err分享
err收藏
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion studyEprenetapopt联合venetoclax和阿扎胞苷TP53-mutated急性髓性白血病: 1期,剂量发现和扩展研究
err2023-04-01
err35
PREAI
errGarcia-Manero, Guillermo; Goldberg, Aaron D.; Winer, Eric S.; Altman, Jessica K.; Fathi, Amir T.; Odenike, Olatoyosi; Roboz, Gail J.; Sweet, Kendra; Miller, Crystal; Wennborg, Anders; Hickman, Denice K.; Kanagal-Shamanna, Rashmi; Kantarjian, Hagop; Lancet, Jeffrey; Komrokji, Rami; Attar, Eyal C.; Sallman, David A.
err分享
err收藏
IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy
err2022-11-24
err7
errOAAI
errKomrokji, Rami; al Ali, Najla; Chan, Onyee; Sweet, Kendra; Kuykendall, Andrew; Lancet, Jeffrey; Padron, Eric; Sallman, David A.
err分享
err收藏
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome
err2022-11-04
err8
errOAAI
errKomrokji, Rami S.; Singh, Avani M.; Al Ali, Najla; Chan, Onyee; Padron, Eric; Sweet, Kendra; Kuykendall, Andrew; Lancet, Jeffrey E.; Sallman, David A.
err分享
err收藏
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations
errCANCER
IF5.1
err2022-09-15
err13
PREAI
errBall, Somedeb; Knepper, Todd C.; Deutsch, Yehuda E.; Samra, Wassim; Watts, Justin M.; Bradley, Terrence J.; Chan, Onyee; Hussaini, Mohammad Omar; Zhang, Ling; Sweet, Kendra L.; Kuykendall, Andrew T.; Talati, Chetasi; Padron, Eric; Komrokji, Rami S.; Lancet, Jeffrey E.; Sallman, David A.
err分享
err收藏